Jupiter Life Line Hospitals Limited Stock Price Today (NSE: JLHL)

Jupiter Life Line Hospitals Limited

1314.60+9.30 (+0.71%)
Market Closed

Fundamental Score

...

Jupiter Life Line Hospitals Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Jupiter Life Line Hospitals Limited share price today is 1314.60, up +0.71% on NSE/BSE as of 19 June 2026. Jupiter Life Line Hospitals Limited (JLHL) is a Mid-cap company in the Hospital sector with a market capitalisation of 9.68K (Cr). The 52-week high for JLHL share price is 1625.00 and the 52-week low is 1178.00. At a P/E ratio of 48.76x, JLHL is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 14.95% and a debt-to-equity ratio of 0.28.

Jupiter Life Line Hospitals Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
1397.90
Low
1211.00
Volume
82.0K
Change
+4.45%

Jupiter Life Line Hospitals Limited share price chart: 4.45% return over the past month. 52-week high ₹1625.00, 52-week low ₹1178.00.

Jupiter Life Line Hospitals Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
1287.301340.001280.401314.6025.10K (Cr)
1340.001340.001299.701305.3017.76K (Cr)
1337.901357.201312.801327.1047.15K (Cr)
1337.801340.001302.101326.1019.31K (Cr)
1365.401365.401330.001337.7030.70K (Cr)
1396.001397.901340.301349.9061.74K (Cr)
1318.901368.001280.001356.6060.74K (Cr)
1343.871363.961305.701311.0014.34K (Cr)
1328.991330.091313.701317.201.17L (Cr)
1348.001359.001318.201328.904.01L (Cr)

Jupiter Life Line Hospitals Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
1340.001340.001280.401314.60-1.90%
1235.001397.901211.001327.10+7.46%
1290.801298.801178.001225.90-5.03%
1203.301335.001202.001281.20+6.47%
1307.601333.801198.801261.80-3.50%
1394.901414.401275.001351.20-3.13%
1460.501491.301357.001393.40-4.59%
1585.101609.901405.001480.10-6.62%
1532.401625.001473.101588.30+3.65%
1410.401550.001400.501520.90+7.83%
1444.701480.101346.001410.40-2.37%
1500.001560.001411.101430.00-4.67%

Returns & Performance

Poor

Return on Equity (ROE)

14.95%

Profit generated per ₹1 of shareholder equity

Good

Return on Capital (ROCE)

17.95%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

21.60%

Average operating profit margin over 5 years

Dividend Yield

0.07%

Annual dividend as % of current share price

Jupiter Life Line Hospitals Limited Valuation Check

Average

Price to Earnings (P/E)

48.76x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

52.84x

Average P/E of all peers in this sector

Market-cap Classification
Mid-cap
Balance of growth potential and stability.

Shareholding Pattern

Excellent

Promoter Holding

40.91%

% shares held by company founders/management

Average

FII Holding

9.06%

% shares held by foreign institutional investors

Good

DII Holding

16.97%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

11.04%

Net profit growth vs same quarter last year

Good

Revenue Growth (Quarterly YoY)

17.48%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

22.20%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

36.51%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

43.62%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.28x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

11.82x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-69.50 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Jupiter Life Line Hospitals Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of JLHL across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Excellent ROCE Performance (17.95%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (21.60%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Strong Revenue Growth (17.48%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (22.20% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (36.51% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (43.62% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.28)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (11.82x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Institutional Confidence (FII+DII: 26.03%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

2 factors identified

Premium Valuation Risk (P/E: 48.76x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Negative Free Cash Flow (₹-69.50 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Jupiter Life Line Hospitals Limited vs Hospital Peers

Peer Comparison - Hospital

Compare Jupiter Life Line Hospitals Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
62.9/100
1315
₹9678.17
48.8
Average
14.95%
Average
17.95%
Good
0.3
Excellent
43.62%
Excellent
22.20%
Excellent
0.07%
69.1/100
993
₹109416.28
77.7
Average
12.72%
Average
14.88%
Average
0.3
Excellent
80.50%
Excellent
46.01%
Excellent
0.13%
50.2/100
8273
₹104825.94
62.7
Average
18.42%
Good
16.64%
Good
0.9
Good
33.72%
Excellent
14.15%
Good
0.26%
55.6/100
961
₹68301.24
67.8
Average
10.13%
Average
11.96%
Average
0.3
Excellent
70.31%
Excellent
10.93%
Good
0.11%
62.2/100
1920
₹39051.19
45.9
Average
24.22%
Excellent
20.75%
Excellent
0.6
Good
43.49%
Excellent
11.88%
Good
0.24%
15.4/100
741
₹34688.15
94.5
Average
8.26%
Poor
10.68%
Average
0.5
Excellent
-7.24%
Poor
-13.71%
Poor
0.75%
61/100
1208
₹33498.00
56.0
Average
16.48%
Good
19.74%
Good
0.3
Excellent
70.15%
Excellent
19.73%
Excellent
0.04%
45.1/100
784
₹27605.54
84.0
Average
18.48%
Good
15.00%
Good
1.4
Average
25.01%
Excellent
22.01%
Excellent
0.00%
51.2/100
480
₹16844.04
145.2
Average
4.76%
Poor
9.99%
Poor
0.5
Good
41.72%
Excellent
26.38%
Excellent
0.00%
54.6/100
1377
₹13410.38
52.8
Average
17.43%
Good
18.69%
Good
0.5
Good
33.66%
Excellent
16.08%
Excellent
0.23%
36.4/100
660
₹10474.40
296.2
Average
5.14%
Poor
8.56%
Poor
1.9
Average
19.34%
Excellent
15.22%
Excellent
0.00%

Jupiter Life Line Hospitals Limited PE Ratio History

Historical price-to-earnings ratio for JLHL — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202529.47₹1393.4047.3x
FY 202428.44₹1562.8055x
FY 202311.12₹1089.9098x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Jupiter Life Line Hospitals Limited Dividend History

Annual cash dividends paid by JLHL — dividend yield 0.07%

Financial YearDividends Paid (₹ Cr)
FY 20256.56 Cr
FY 20245.65 Cr
FY 20235.09 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Jupiter Life Line Hospitals Limited Quarterly Performance

Latest quarterly metrics for JLHL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

17.48%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

11.04%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

22.20%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

43.62%

Compounded annual net profit growth over 5 years

Jupiter Life Line Hospitals Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for JLHL — calculated from daily price history

64RSI 14
Neutral — RSI 64

Momentum is balanced — neither overbought nor oversold.

SMA 50
1271
▲ Price above SMA 50 — Short-term bullish
SMA 200
1375
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
63K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Jupiter Life Line Hospitals Limited Financial Statements

Annual income statement, balance sheet and cash flow for Jupiter Life Line Hospitals Limited (JLHL) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Jupiter Life Line Hospitals Limited

About JLHL (Jupiter Life Line Hospitals Limited)

Jupiter Life Line Hospitals Limited is a sprawling network of healthcare institutions woven into the fabric of India's medical landscape. Beyond mere brick and mortar, these hospit...als stand as modern cathedrals of healing, places where cutting-edge technology intersects with compassionate care. Step inside, and you're met with a symphony of purposeful activity – the hushed murmur of consultations, the soft beeping of monitors, and the quiet reassurance offered by dedicated medical professionals. From the inviting lobbies adorned with calming art to the meticulously sterilized operating rooms, every detail is thoughtfully designed to foster an environment of trust and well-being. JLHL strives to be the destination where patients can embark on their journey towards recovery, guided by expertise and unwavering support. Within Jupiter Life Line Hospitals, a vast ecosystem of specialized medical disciplines coexists, forming a holistic approach to patient care. Each department functions as a center of excellence, staffed by teams of highly skilled physicians, surgeons, nurses, and technicians who are all dedicated to their craft. From complex cardiovascular procedures to delicate neurosurgical interventions, the breadth of services available is comprehensive. The hospital prides itself on early adoption of innovative medical techniques, and its continued investment in cutting edge medical advancements. This is coupled with a commitment to evidence-based practices, ensuring that patients receive the most effective and appropriate treatments available, tailored to their individual needs. More than just a provider of medical services, Jupiter Life Line Hospitals aspires to be a partner in the communities it serves. Recognizing that true health extends beyond the confines of the hospital walls, JLHL actively engages in outreach programs, health education initiatives, and community health screenings. By promoting preventative care and empowering individuals to take control of their own well-being, the hospital seeks to foster a culture of health and wellness that extends far beyond its immediate patient base. This commitment to community engagement underscores JLHL's belief that healthcare is a shared responsibility, and that by working together, the health and well-being of the entire community can be improved.

Company Details

Symbol:JLHL
Industry:Hospital
Sector:Hospital

Key Leadership

Dr. Ajay Pratap Thakker
Chairman & MD
Dr. Ankit Ajay Thakker
Joint MD, CEO & Executive Director
Mr. Harshad Purani
CFO and President of Administration & Head of Corporate Social Responsibility

Corporate Events

Recent
Ex-Dividend Date

JLHL Share Price: Frequently Asked Questions

What is the current share price of Jupiter Life Line Hospitals Limited?

Jupiter Life Line Hospitals Limited (JLHL) trades at ₹1314.60 on NSE and BSE. Market cap ₹9.68K (Cr). Educational data only.

What is the P/E ratio of Jupiter Life Line Hospitals Limited?

Jupiter Life Line Hospitals Limited has a P/E of 48.76x vs industry average 52.84x.

What is the Bull Run score for Jupiter Life Line Hospitals Limited?

Jupiter Life Line Hospitals Limited has a Bull Run score of 62.9/100 based on 25+ financial parameters.

Does Jupiter Life Line Hospitals Limited pay dividends?

Jupiter Life Line Hospitals Limited has a dividend yield of 0.07%. Past dividends don't guarantee future payments.

What is the ROE of Jupiter Life Line Hospitals Limited?

Jupiter Life Line Hospitals Limited has ROE of 14.95%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Jupiter Life Line Hospitals Limited?

Jupiter Life Line Hospitals Limited has debt-to-equity of 0.28.

Is Jupiter Life Line Hospitals Limited a good investment?

Bull Run gives Jupiter Life Line Hospitals Limited a score of 62.9/100. This is not investment advice — consult a SEBI-registered advisor.